BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2440312)

  • 21. Dual actions of 1,25-dihydroxycholecalciferol on intracellular Ca2+ in GH4C1 cells: evidence for effects on voltage-operated Ca2+ channels and Na+/Ca2+ exchange.
    Tornquist K; Tashjian AH
    Endocrinology; 1989 Jun; 124(6):2765-76. PubMed ID: 2541998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of action of inhibitors of prolactin secretion in GH3 pituitary cells. II. Blockade of voltage-dependent Ca2+ channels.
    Wolfe SE; Brostrom MA
    Mol Pharmacol; 1986 Apr; 29(4):420-6. PubMed ID: 2422534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spontaneous and corticotropin-releasing factor-induced cytosolic calcium transients in corticotrophs.
    Guérineau N; Corcuff JB; Tabarin A; Mollard P
    Endocrinology; 1991 Jul; 129(1):409-20. PubMed ID: 1647305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium channel agonists and antagonists: effects of chronic treatment on pituitary prolactin synthesis and intracellular calcium.
    Hinkle PM; Jackson AE; Thompson TM; Zavacki AM; Coppola DA; Bancroft C
    Mol Endocrinol; 1988 Nov; 2(11):1132-8. PubMed ID: 3221879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of calcium antagonist drugs on calcium currents in mammalian skeletal muscle fibers.
    Walsh KB; Bryant SH; Schwartz A
    J Pharmacol Exp Ther; 1986 Feb; 236(2):403-7. PubMed ID: 2418195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of sodium channels and two types of calcium channels in the regulation of adrenocorticotropin release.
    Childs GV; Marchetti C; Brown AM
    Endocrinology; 1987 May; 120(5):2059-69. PubMed ID: 2436894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the Ca(2+)-channel agonist Bay K 8644 on the contractile responses in human placental veins.
    Barrús MT; Reviriego J; Marín J
    J Auton Pharmacol; 1996 Jun; 16(3):161-7. PubMed ID: 8884463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Ca2+ antagonists on 45Ca2+ uptake by rat whole brain P1 and P2 fractions.
    Honda H; Shibuya T; Salafsky B
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):463-70. PubMed ID: 2781143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferential block of T-type calcium channels by neuroleptics in neural crest-derived rat and human C cell lines.
    Enyeart JJ; Biagi BA; Mlinar B
    Mol Pharmacol; 1992 Aug; 42(2):364-72. PubMed ID: 1355264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 12-O-tetradecanoyl-phorbol-13-acetate decreases influx of extracellular Ca2+ induced by depolarization in GH4C1 cells: effects of pretreatment with 1,25-dihydroxycholecalciferol.
    Tornquist K; Tashjian AH
    Endocrinology; 1990 Apr; 126(4):2068-78. PubMed ID: 1690636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and characterization of voltage-sensitive calcium channels in neuronal clonal cell lines.
    Freedman SB; Dawson G; Villereal ML; Miller RJ
    J Neurosci; 1984 Jun; 4(6):1453-67. PubMed ID: 6202853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physiological and pharmacological correlates of calcium antagonist receptors.
    Wagner JA; Reynolds IJ; Snyder SH
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S1-9. PubMed ID: 2455102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of calmodulin inhibitors and protein kinase C inhibitors with voltage-dependent calcium channels.
    Greenberg DA; Carpenter CL; Messing RO
    Brain Res; 1987 Feb; 404(1-2):401-4. PubMed ID: 2436710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. omega-Conotoxin exerts functionally distinct low and high affinity effects in the neuronal cell line NG108-15.
    Werth JL; Hirning LD; Thayer SA
    Mol Pharmacol; 1991 Nov; 40(5):742-9. PubMed ID: 1944242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of interactions of methylmercury with Ca2+ channels in synaptosomes and pheochromocytoma cells: radiotracer flux and binding studies.
    Shafer TJ; Contreras ML; Atchison WD
    Mol Pharmacol; 1990 Jul; 38(1):102-13. PubMed ID: 2164628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological characterization of two calcium currents in GH3 cells.
    Simasko SM; Weiland GA; Oswald RE
    Am J Physiol; 1988 Mar; 254(3 Pt 1):E328-36. PubMed ID: 2450473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent inhibition of native TREK-1 K+ channels by selected dihydropyridine Ca2+ channel antagonists.
    Liu H; Enyeart JA; Enyeart JJ
    J Pharmacol Exp Ther; 2007 Oct; 323(1):39-48. PubMed ID: 17622574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition by antipsychotic drugs of L-type Ca2+ channel current in PC12 cells.
    Ito K; Nakazawa K; Koizumi S; Liu M; Takeuchi K; Hashimoto T; Ohno Y; Inoue K
    Eur J Pharmacol; 1996 Oct; 314(1-2):143-50. PubMed ID: 8957230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxin of the marine alga Prymnesium patelliferum enhances voltage dependent Ca(2+)-currents, elevates the cytosolic Ca(2+)-concentration and facilitates hormone release in clonal rat pituitary cells.
    Kolderup J; Meldahl AS; Eriksen S; Haug E; Fonnum F; Sand O
    Acta Physiol Scand; 1995 Jul; 154(3):321-7. PubMed ID: 7572230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of the veratridine-induced increase in cytosolic Ca2+ and respiration by Ca2+ antagonists in isolated cardiac myocytes.
    Moreno-Sánchez R; Hansford RG
    Int J Biochem; 1991; 23(9):889-96. PubMed ID: 1773894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.